[1] 张小娥,张彩莲.早期慢性阻塞性肺疾病研究进展[J].临床误诊误治,2017,30(6):112-116. [2] 罗敏涛, 王玉梅, 李森龙, 等.慢性阻塞性肺病患者睡眠质量与肺功能的关系研究[J].实用预防医学,2019,26(1):78-80. [3] 李云辉,潘彬,杨凯,等.慢性阻塞性肺疾病患者巨噬细胞刺激蛋白和炎性因子及生活质量的关系研究[J].临床肺科杂志,2019,24(3):19-23. [4] 胡静. COPD合并肺癌的发病机制与治疗进展[J]. 国际呼吸杂志, 2016, 36(36):607-611. [5] 李云辉, 潘彬, 杨凯,等. 慢性阻塞性肺疾病患者巨噬细胞刺激蛋白和炎性因子及生活质量的关系研究[J]. 临床肺科杂志, 2019, 24(3):19-23. [6] 杨超勉,韦球,黄天霞,等.慢性阻塞性肺疾病治疗期间呼出气冷凝液中炎症因子的变化及临床意义[J].海南医学,2017,28(10):1611-1613 [7] 葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013: 21-27. [8] 孙霞,张志鹏,温煦,等.慢性阻塞性肺病患者外周血单个核细胞自噬与疾病状态的相关性研究[J].中国医师进修杂志,2019,42(3):238-244. [9] Kwon N,Amin M,Hui DS,et al.Validity of the chronic obstructive pulmonary disease assessment test translated into local languages for Asian patients [J].Chest,2013,143(3):703-710. [10] Zhao C,Bu X,Wang W,et al.GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation[J].PLoS One,2014,9(1):e85058. [11] Hu W,Li L,Yang M,et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans[J].J Clin Endocrinol Metab,2013,98(1):290-298. [12] Suraj KP,Jyothi E,Rakhi R.Role of domiciliary noninvasive ventilation in chronic obstructive pulmonary disease patients requiring repeated admissions with acute type I/respiratory failure: a prospective cohort study[J].Indian J Crit Care Med,2018,22(6):397-401. [13] Stratev V,Petkova D,Dimitrova V,et al.Comorbidities of COPD in Bulgarian patients-prevalence and association with severity and inflammation[J].Folia Med(Plovdiv),2018,60(1):102-109. [14] Hunt T,Williams MT,Olds TS,et al.Patterns of time use across the chronic obstructive pulmonary disease severity spectrum[J].Int J Environ Res Public Health,2018,15(3)533-536. [15] Karoli NA,Rebrov AP.Sudden cardiac death in patients with chronic obstructive pulmonary disease[J].Kardiologiia,2017,57(2):83-90.
2021, Vol. 28 
